Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE50.5700
- TODAY'S CHANGE (%)1.1900 (2.4099%)
- Bid / Lots50.4800/ 4
- Ask / Lots50.6500/ 1
- Open / Previous Close50.2500 / 49.3800
- Day Range
- 52 Week Range
- Volume283,035
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 1501 | 50.25 |
| 09:34 ET | 3111 | 50.3 |
| 09:36 ET | 100 | 50.35 |
| 09:38 ET | 422 | 50.41 |
| 09:39 ET | 2276 | 50.86 |
| 09:43 ET | 892 | 50.98 |
| 09:45 ET | 200 | 51 |
| 09:48 ET | 100 | 50.915 |
| 09:50 ET | 1075 | 51.45 |
| 09:52 ET | 7170 | 51.135 |
| 09:54 ET | 100 | 50.99 |
| 09:56 ET | 200 | 51.115 |
| 09:57 ET | 100 | 51.11 |
| 09:59 ET | 400 | 51.13 |
| 10:01 ET | 900 | 51.4 |
| 10:03 ET | 1100 | 51.07 |
| 10:06 ET | 400 | 50.9 |
| 10:08 ET | 250 | 50.815 |
| 10:10 ET | 300 | 50.81 |
| 10:12 ET | 700 | 50.765 |
| 10:14 ET | 1440 | 51.03 |
| 10:15 ET | 300 | 51.25 |
| 10:19 ET | 100 | 51.06 |
| 10:21 ET | 200 | 51.32 |
| 10:24 ET | 121 | 51.39 |
| 10:32 ET | 1000 | 51.41 |
| 10:33 ET | 504 | 51.49 |
| 10:35 ET | 1966 | 51.83 |
| 10:37 ET | 200 | 51.675 |
| 10:39 ET | 2440 | 51.45 |
| 10:42 ET | 400 | 51.49 |
| 10:44 ET | 100 | 51.34 |
| 10:46 ET | 900 | 51.07 |
| 10:48 ET | 400 | 51.01 |
| 10:50 ET | 600 | 50.895 |
| 10:51 ET | 6580 | 51.36 |
| 10:55 ET | 541 | 51.46 |
| 10:57 ET | 1200 | 51.64 |
| 11:00 ET | 801 | 51.64 |
| 11:02 ET | 800 | 51.44 |
| 11:04 ET | 1800 | 51.515 |
| 11:08 ET | 200 | 51.5 |
| 11:09 ET | 800 | 51.58 |
| 11:11 ET | 2252 | 51.76 |
| 11:13 ET | 1400 | 51.98 |
| 11:15 ET | 700 | 51.87 |
| 11:18 ET | 926 | 51.89 |
| 11:20 ET | 200 | 51.885 |
| 11:22 ET | 8417 | 52.08 |
| 11:24 ET | 1100 | 52.01 |
| 11:26 ET | 200 | 51.89 |
| 11:27 ET | 400 | 52.04 |
| 11:29 ET | 900 | 51.98 |
| 11:31 ET | 800 | 52.15 |
| 11:33 ET | 3639 | 52 |
| 11:36 ET | 1500 | 51.73 |
| 11:38 ET | 600 | 51.43 |
| 11:40 ET | 3043 | 51.85 |
| 11:42 ET | 500 | 51.94 |
| 11:44 ET | 1100 | 51.865 |
| 11:45 ET | 100 | 51.98 |
| 11:47 ET | 100 | 51.97 |
| 11:49 ET | 1000 | 51.98 |
| 11:51 ET | 1200 | 52.11 |
| 11:54 ET | 2800 | 51.8742 |
| 11:56 ET | 1900 | 51.79 |
| 11:58 ET | 400 | 51.665 |
| 12:00 ET | 200 | 51.72 |
| 12:02 ET | 100 | 51.74 |
| 12:03 ET | 591 | 51.89 |
| 12:05 ET | 900 | 51.81 |
| 12:07 ET | 300 | 51.82 |
| 12:09 ET | 400 | 51.785 |
| 12:12 ET | 300 | 51.785 |
| 12:14 ET | 100 | 51.785 |
| 12:16 ET | 700 | 51.855 |
| 12:18 ET | 1200 | 51.795 |
| 12:20 ET | 900 | 51.795 |
| 12:21 ET | 616 | 51.815 |
| 12:23 ET | 1100 | 52.03 |
| 12:25 ET | 2020 | 52.15 |
| 12:27 ET | 1300 | 52.085 |
| 12:30 ET | 100 | 52.065 |
| 12:32 ET | 200 | 52.105 |
| 12:34 ET | 2232 | 52.11 |
| 12:36 ET | 300 | 51.94 |
| 12:38 ET | 1300 | 52.07 |
| 12:39 ET | 300 | 52.13 |
| 12:41 ET | 600 | 52.145 |
| 12:43 ET | 1100 | 52.06 |
| 12:48 ET | 800 | 51.96 |
| 12:50 ET | 200 | 51.905 |
| 12:52 ET | 500 | 52.12 |
| 12:54 ET | 1690 | 52.3299 |
| 12:56 ET | 300 | 52.27 |
| 12:57 ET | 1597 | 52.365 |
| 12:59 ET | 5621 | 51.79 |
| 01:03 ET | 300 | 51.86 |
| 01:06 ET | 500 | 51.645 |
| 01:08 ET | 1550 | 51.625 |
| 01:10 ET | 100 | 51.55 |
| 01:12 ET | 400 | 51.555 |
| 01:14 ET | 850 | 51.24 |
| 01:15 ET | 1000 | 51.435 |
| 01:17 ET | 1010 | 51.425 |
| 01:19 ET | 406 | 51.43 |
| 01:21 ET | 600 | 51.44 |
| 01:24 ET | 200 | 51.42 |
| 01:26 ET | 9172 | 51.46 |
| 01:28 ET | 2400 | 51 |
| 01:30 ET | 1727 | 50.78 |
| 01:32 ET | 100 | 50.94 |
| 01:33 ET | 100 | 50.93 |
| 01:35 ET | 1099 | 50.94 |
| 01:37 ET | 2304 | 50.9 |
| 01:39 ET | 1200 | 51.0799 |
| 01:42 ET | 500 | 51.08 |
| 01:44 ET | 1342 | 51.16 |
| 01:46 ET | 200 | 51.24 |
| 01:48 ET | 464 | 51.255 |
| 01:50 ET | 100 | 51.255 |
| 01:51 ET | 300 | 51.255 |
| 01:55 ET | 1200 | 51.26 |
| 01:57 ET | 1715 | 50.93 |
| 02:00 ET | 200 | 50.9 |
| 02:02 ET | 300 | 50.9 |
| 02:04 ET | 800 | 50.91 |
| 02:06 ET | 27108 | 51.145 |
| 02:08 ET | 1200 | 51.125 |
| 02:09 ET | 100 | 51.23 |
| 02:11 ET | 300 | 50.99 |
| 02:13 ET | 900 | 51.24 |
| 02:15 ET | 300 | 51.25 |
| 02:18 ET | 186 | 51.245 |
| 02:20 ET | 200 | 51.27 |
| 02:22 ET | 2654 | 50.81 |
| 02:24 ET | 400 | 51.02 |
| 02:29 ET | 1100 | 50.74 |
| 02:31 ET | 200 | 50.72 |
| 02:33 ET | 1105 | 50.765 |
| 02:36 ET | 700 | 50.63 |
| 02:38 ET | 100 | 50.63 |
| 02:40 ET | 1053 | 50.625 |
| 02:42 ET | 100 | 50.64 |
| 02:44 ET | 900 | 50.66 |
| 02:45 ET | 200 | 50.655 |
| 02:47 ET | 300 | 50.65 |
| 02:49 ET | 1100 | 50.57 |
| 02:51 ET | 100 | 50.55 |
| 02:54 ET | 600 | 50.57 |
| 02:56 ET | 100 | 50.57 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 2.9B | -24.7x | --- |
Geron Corp | 2.9B | -14.4x | --- |
Morphic Holding Inc | 2.8B | -16.1x | --- |
MoonLake Immunotherapeutics | 3.1B | -66.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.2x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark McKenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Lisa Bollinger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.04 |
Book Value | $7.86 |
P/E Ratio | -24.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
